Tbx3 represses E-cadherin expression and enhances melanoma invasiveness

Cancer Research

Volumn 68, Issue 19, 2008, Pages 7872-7881

  Rodriguez, Mercedes ^a   Aladowicz, Ewa ^c   Lanfrancone, Luisa ^c   Goding, Colin R ^a,b  

^a MARIE CURIE RESEARCH INSTITUTE   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CYCLIN DEPENDENT KINASE INHIBITOR 1; MESSENGER RNA; T BOX TRANSCRIPTION FACTOR; T BOX TRANSCRIPTION FACTOR 2; T BOX TRANSCRIPTION FACTOR 3; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER TISSUE; CELL AGING; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; IN VITRO STUDY; MELANOMA; MELANOMA CELL; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION SITE; UPREGULATION;

BASE SEQUENCE; CADHERINS; CALCIUM SIGNALING; CELL ADHESION; CELL AGING; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; NEOPLASM INVASIVENESS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; T-BOX DOMAIN PROTEINS; TUMOR CELLS, CULTURED;

EID: 54249133490     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-0301     Document Type: Article

References (46)

1. Bennett DC. How to make a melanoma: what do we know of the primary clonal events? Pigment Cell Melanoma Res 2008;21:27-38.
2. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature 2002;417:949-54.
3. Michaloglou C, Vredeveld LC, Soengas MS, et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 2005;436:720-4.
4. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997;88:593-602.
5. Gray-Schopfer VC, Cheong SC, Chong H, et al. Cellular senescence in naevi and immortalisation in melanoma: a role for p16? Br J Cancer 2006;95:496-505.
6. Sharpless E, Chin L. The INK4a/ARF locus and melanoma. Oncogene 2003;22:3092-8.
7. Sviderskaya EV, Gray-Schopfer VC, Hill SP, et al. p16/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: possible implications for melanoma progression. J Natl Cancer Inst 2003;95:723-32.
8. Haass NK, Smalley KS, Li L, Herlyn M. Adhesion, migration and communication in melanocytes and melanoma. Pigment Cell Res 2005;18:150-9.
9. Naiche LA, Harrelson Z, Kelly RG, Papaioannou VE. T-box genes in vertebrate development. Annu Rev Genet 2005;39:219-39.
10. Carreira S, Dexter TJ, Yavuzer U, Easty DJ, Goding CR. Brachyury-related transcription factor Tbx2 and repression of the melanocyte-specific TRP-1 promoter. Mol Cell Biol 1998;18:5099-108.
11. Jacobs JJ, Keblusek P, Robanus-Maandag E, et al. Senescence bypass screen identifies Tbx2, which represses cdkn2a (p19ARF) and is amplified in a subset of human breast cancers. Nat Genet 2000;26:291-9.
12. Habets PE, Moorman AF, Clout DE, et al. Cooperative action of Tbx2 and Nkx2.5 inhibits ANF expression in the atrioventricular canal: implications for cardiac chamber formation. Genes Dev 2002;16:1234-46.
13. Lingbeek ME, Jacobs JJ, Van Lohuizen M. The T-box repressors TBX2 and TBX3 specifically regulate the tumour suppressor gene p14ARF via a variant T-site in the initiator. J Biol Chem 2002;277:26120-7.
14. Prince S, Carreira S, Vance KW, Abrahams A, Goding CR. Tbx2 directly represses the expression of the p21(WAF1) cyclin-dependent kinase inhibitor. Cancer Res 2004;64:1669-74.
15. Coll M, Seidman JG, Muller CW. Structure of the DNA-bound T-box domain of human TBX3, a transcription factor responsible for ulnar-mammary syndrome. Structure (Camb) 2002;10:343-56.
16. Brummelkamp TR, Kortlever RM, Lingbeek M, et al. TBX-3, the gene mutated in Ulnar-Mammary Syndrome, is a negative regulator of p19ARF and inhibits senescence. J Biol Chem 2002;277:6567-72.
17. Hoogaars WM, Barnett P, Rodriguez M, et al. TBX3 and its splice variant TBX3 + exon 2a are functionally similar. Pigment Cell Melanoma Res 2008;21:379-87.
18. Vance KW, Carreira S, Brosch G, Goding CR. Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas. Cancer Res 2005;65:2260-8.
19. Jonsson G, Dahl C, Staaf J, et al. Genomic profiling of malignant melanoma using tiling-resolution array CGH. Oncogene 2007;26:4738-48.
20. Mahlamaki EH, Barlund M, Tanner M, et al. Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer. Genes Chromosomes Cancer 2002;35:353-8.
21. Sinclair CS, Adem C, Naderi A, et al. Tbx2 is preferentially amplified in BRCA1- and BRCA2-related breast tumours. Cancer Res 2002;62:3587-91.
22. Hoek K, Rimm DL, Williams KR, et al. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res 2004;64:5270-82.
23. Lomnytska M, Dubrovska A, Hellman U, Volodko N, Souchelnytskyi S. Increased expression of cSHMT, Tbx3 and utrophin in plasma of ovarian and breast cancer patients. Int J Cancer 2006;118:412-21.
24. Fan W, Huang X, Chen C, Gray J, Huang, T. TBX3 and its isoform TBX3+2a are functionally distinctive in inhibition of senescence and are overexpressed in a subset of breast cancer cell lines. Cancer Res 2004;64:5132-9.
25. Lyng H, Brovig RS, Svendsrud DH, et al. Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer. BMC Genomics 2006;7:268-73.
26. Yarosh W, Barrientos T, Esmailpour T, et al. TBX3 is overexpressed in breast cancer and represses p14 ARF by interacting with histone deacetylases. Cancer Res 2008;68:693-9.
27. Carreira S, Liu B, Goding CR. The gene encoding the T-box transcription factor Tbx2 is a target for the microphthalmia-associated transcription factor in melanocytes. J Biol Chem 2000;275:21920-7.
28. Carreira S, Goodall J, Aksan I, et al. Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression. Nature 2005;433:764-9.
29. Johansson P, Pavey S, Hayward N. Confirmation of a BRAF mutation-associated gene expression signature in melanoma. Pigment Cell Res 2007;20:216-21.
30. Batlle E, Sancho E, Franci C, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000;2:84-9.
31. Cano A, Perez-Moreno MA, Rodrigo I, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000;2:76-83.
32. Hiroi Y, Kudoh S, Monzen K, et al. Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation. Nat Genet 2001;28:276-80.
33. Krause A, Zacharias W, Camarata T, et al. Tbx5 and Tbx4 transcription factors interact with a new chicken PDZ-LIM protein in limb and heart development. Dev Biol 2004;273:106-20.
34. Lamolet B, Pulichino AM, Lamonerie T, et al. A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins. Cell 2001;104:849-59.
35. Messenger NJ, Kabitschke C, Andrews R, et al. Functional specificity of the Xenopus T-domain protein Brachyury is conferred by its ability to interact with Smad1. Dev Cell 2005;8:599-610.
36. Murakami M, Nakagawa M, Olson EN, Nakagawa O. A WW domain protein TAZ is a critical coactivator for Tbx5, a transcription factor implicated in Holt-Oram syndrome. Proc Natl Acad Sci U S A 2005;102:18034-9.
37. Stennard FA, Costa MW, Elliott DA, et al. Cardiac T-box factor Tbx20 directly interacts with Nkx2-5, GATA4, and GATA5 in regulation of gene expression in the developing heart. Dev Biol 2003;262:206-24.
38. Demay F, Bilican B, Rodriguez M, et al. T-box factors: targeting to chromatin and interaction with the histone H3 N-terminal tail. Pigment Cell Res 2007;20:279-87.
39. Kispert A, Herrmann BG. The Brachyury gene encodes a novel DNA-binding protein. EMBO J 1993;12:3211-20.
40. Müller CW, Herrmann BG. Crystallographic structure of the T domain-DNA complex of the Brachyury transcription factor. Nature 1997;389:884-9.
41. Zhang H, Rosdahl I. Deletion in p16INK4a and loss of p16 expression in human skin primary and metastatic melanoma cells. Int J Oncol 2004;24:331-5.
42. Bilican B, Goding CR. Cell cycle regulation of the T-box transcription factor Tbx2. Exp Cell Res 2006;312:2358-66.
43. Naiche LA, Papaioannou VE. Loss of Tbx4 blocks hindlimb development and affects vascularization and fusion of the allantois. Development 2003;130:2681-93.
44. Rodriguez-Esteban C, Tsukui T, Yonei S, Magallon J, Tamura K, Izpisua Belmonte JC. The T-box genes Tbx4 and Tbx5 regulate limb outgrowth and identity. Nature 1999;398:814-8.
45. Stennard FA, Costa MW, Lai D, et al. Murine T-box transcription factor Tbx20 acts as a repressor during heart development, and is essential for adult heart integrity, function and adaptation. Development 2005;132:2451-62.
46. Takeuchi JK, Koshiba-Takeuchi K, Matsumoto K, et al. Tbx5 and Tbx4 genes determine the wing/leg identity of limb buds. Nature 1999;398:810-4.